Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

What Constitutes a Positive MRI for Clinical Trial Recruitment of Psoriatic Arthritis Patients With Axial Involvement?

Publikation: Bidrag til tidsskriftReviewpeer review


  1. Is Real-world Evidence Really Real?

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

There has been a resurgence of interest in defining the axial inflammation component of psoriatic arthritis (PsA) since recent randomized controlled trials (RCTs) raised the possibility that this entity may respond differentially to therapeutics compared to patients with axial spondyloarthritis. A workshop was conducted during the 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis annual meeting to review the literature on diagnosing PsA and to determine which criteria might be most appropriate. There was quite strong agreement that magnetic resonance imaging (MRI) had an important role to play in helping to define axial inflammation in PsA and that a data-driven methodology for generating optimal MRI quantitative cut-offs for lesions in the sacroiliac joints and/or spine that reflect imaging typical of axial inflammation in PsA would be most desirable.

TidsskriftJournal of Rheumatology
Udgave nummer6 Suppl 1
Sider (fra-til)72-74
Antal sider3
StatusUdgivet - jun. 2022

Bibliografisk note

Copyright © 2022 by The Journal of Rheumatology.

ID: 79732713